Since the approval of vosoritide in 2021, a need was created for a treatment guideline for support clinicians. An international collaborative of leading experts and patient…
Read More
Achondroplasia is the most common skeletal dysplasia and is characterized by a variety of medical, functional and psychosocial challenges across the lifespan. There is variability in…
Read More
These treatment pathways were developed by the type 2 diabetes subgroup of the PES Diabetes SIG, using evidence base when available in combination with expert clinical…
Read More
Lipid management algorithms were developed by SIG members as a resource for use in clinical care and trainee education. Relevant guidelines were applied in the development…
Read More
The prevalence of obesity and associated comorbidities is rising. This material summarized the anti-obesity medications adapted by the PES Obesity Special Interest Group from the original…
Read More